We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Drug-delivery Technology Leads to Sustained Antibody Production

News   Mar 10, 2020 | Original story from the National Institutes of Health

 
Drug-delivery Technology Leads to Sustained Antibody Production

Credit: iStock

 
 
Advertisement
 

RELATED ARTICLES

Poor Air Quality Linked to Increased COVID-19 Deaths in Italy?

News

Environmental and health researchers in Denmark and Italy demonstrate a probable correlation between air pollution and coronavirus-related mortality in two of the worst affected regions in northern Italy: Lombardy and Emilia Romagna

READ MORE

Nanovesicle Delivery Could Help Treat Brain Cancers and Neurological Diseases

News

A targeted therapy currently being studied for treatment of certain cancers including glioblastoma, could also be used to treat other neurologic diseases, according to new research.

READ MORE

Genetic System Can Reduce COVID-19 Vaccine Development Timeframe

News

A multidisciplinary team at The University of Texas Medical Branch at Galveston working to combat the COVID-19 virus has a system that will unlock researchers’ ability to more quickly develop and evaluate developing vaccines, diagnose infected patients and explore whether or how the virus has evolved.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE